RecruitingNCT06405438

Comparison of the Efficacy of Peloid Therapy and Paraffin Treatment in Carpal Tunnel Syndrome


Sponsor

Beylikduzu State Hospital

Enrollment

60 participants

Start Date

Oct 10, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

This study compares the effectiveness of peloid therapy and paraffin treatment in carpal tunnel syndrome. Patients who have already received 2 weeks of peloid therapy or 15 sessions of paraffin treatment will be assessed. Pain and symptom severity are assessed using the Visual Analog Scale (VAS) and Boston Carpal Tunnel Syndrome Questionnaire (BCTQ). Electrophysiological examinations will also be conducted at the same time points: baseline, 4 weeks post-treatment, and a 12-week follow-up.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Inclusion Criteria3

  • Patients aged between 18 and 65 years old.
  • Patients diagnosed with mild to moderate carpal tunnel syndrome based on electrophysiological evaluations.
  • Patients experiencing symptoms for a minimum of 3 months.

Exclusion Criteria2

  • Patients diagnosed with neuropathic conditions such as polyneuropathy, brachial plexopathy, or thoracic outlet syndrome.
  • Patients with a history of previous injections or surgery for carpal tunnel syndrome.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNo intervention

No intervention.


Locations(1)

Beylikdüzü State Hospital

Istanbul, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06405438


Related Trials